CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank33
3Y CAGR-13.9%
5Y CAGR-7.9%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-13.9%/yr
vs +3.0%/yr prior
5Y CAGR
-7.9%/yr
Recent deceleration
Acceleration
-16.9pp
Decelerating
Percentile
P33
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$98.57M-12.9%
2024$113.11M+5.0%
2023$107.70M-30.3%
2022$154.50M+0.7%
2021$153.35M+2.9%
2020$148.97M-11.5%
2019$168.38M+22.6%
2018$137.38M+16.5%
2017$117.88M+58.0%
2016$74.63M-